Androgens may modulate the physiology of vaginal tissue and contribute to female genital sexual arousal. Men who watch a sexually explicit movie have an average increase of 35% in testosterone, peaking at 60–90 minutes after the end of the film, but no increase is seen in men who watch sexually neutral films. Studies conducted in rats have indicated that their degree of sexual arousal is sensitive to reductions in testosterone. Testosterone levels follow a circadian rhythm that peaks early each day, regardless of sexual activity. Regular monitoring during treatment typically includes hematocrit levels every 3-6 months to prevent polycythemia, along with PSA monitoring in men over 40. In male rats, dexamethasone for 7 days caused severe testicular pathology such as hypospermatogenesis, germ cell degeneration and depletion, epithelial vacuolization, and degenerated Leydig cells (Azimi Zangabad et al., 2023). Experiments focusing on suppressing spermatogenesis and its effects on receptor expression found that PR-B, a specific isoform of the progesterone receptor, was expressed in the rat testis at both transcriptional and protein levels (Lue et al., 2013). Functional AR in Leydig cells is required for steroidogenic function, as spermatogenic arrest predominately at the round spermatid stage was observed when anti-Müllerian hormone receptor-2 (Amhr2) promoter-driven Cre was used to conditionally delete Ar in Leydig cells (Xu et al., 2007). Therefore, androgen signaling acts through somatic cells to regulate sperm production. It is essential to understand the complex biosynthetic pathways, site-specific production, and diverse actions of these hormones, in particular their roles in supporting the male reproductive system. Steroid hormones are integral to various physiological processes, including cellular metabolism, growth, immune function, and reproduction. In addition to focusing on hormone receptor function and localization within the testis, we will highlight the effects of altered receptor signaling, including the consequences of reduced and excess signaling activity. 5α-Reductase is highly expressed in the male reproductive organs (including the prostate gland, seminal vesicles, and epididymides), skin, hair follicles, and brain and aromatase is highly expressed in adipose tissue, bone, and the brain. Approximately 5 to 7% of testosterone is converted by 5α-reductase into 5α-DHT, with circulating levels of 5α-DHT about 10% of those of testosterone, and approximately 0.3% of testosterone is converted into estradiol by aromatase. Finally, increasing levels of testosterone through a negative feedback loop act on the hypothalamus and pituitary to inhibit the release of GnRH and FSH/LH, respectively. In addition to 6β- and 16β-hydroxytestosterone, 1β-, 2α/β-, 11β-, and 15β-hydroxytestosterone are also formed as minor metabolites. The 6β-hydroxylation of testosterone is catalyzed mainly by CYP3A4 and to a lesser extent CYP3A5 and is responsible for 75 to 80% of cytochrome P450-mediated testosterone metabolism. In addition to conjugation and the 17-ketosteroid pathway, testosterone can also be hydroxylated and oxidized in the liver by cytochrome P450 enzymes, including CYP3A4, CYP3A5, CYP2C9, CYP2C19, and CYP2D6. A small portion of approximately 3% of testosterone is reversibly converted in the liver into androstenedione by 17β-HSD. In the hepatic 17-ketosteroid pathway of testosterone metabolism, testosterone is converted in the liver by 5α-reductase and 5β-reductase into 5α-DHT and the inactive 5β-DHT, respectively. The decrease in the levels of PIP2, an inhibitor of ATP-mediated activation of K+ATP channels, promotes the closing of these channels causing an increase in membrane resistance and depolarization of the cell. In both models, the testes lack full complements of germ cells, which decreases the complexity of the signals received by Sertoli cells. Furthermore, the genes identified in the microarray studies performed thus far show relatively little overlap and the number of genes displaying a two-fold or greater change in expression are limited.33 Interestingly, a relatively high percentage of the regulated genes are inhibited by testosterone. First, the integrity of the blood testis barrier (BTB) is compromised, which exposes post meiotic germ cells, formerly in a secluded specialized environment, to autoimmune attack and cytotoxic factors.22,23 Second, there is a block in conversion of round spermatids to elongated spermatids due to a defect in cell adhesion that causes the premature detachment of round spermatids from Sertoli cells.21,24,25 Third, fully mature spermatozoa cannot be released from Sertoli cells and the germ cells are phagocytized by the Sertoli cells.21 The localization of AR to germ cells is controversial with some studies finding AR positive germ cells and other studies showing that there is no AR in germ cells (reviewed by Wang and colleagues).12 Functional evidence suggests that if AR is expressed in germ cells it is not required. Testosterone levels are similarly elevated in rodent testes.6–10 Thus far, the specific physiologic requirements for high levels of testosterone in the testis are not known. Testosterone is produced by Leydig cells in the interstitial space of the testis. High triglycerides relative to HDL cholesterol is a marker of insulin resistance and metabolic dysfunction. Fasting insulin levels above twelve mIU per milliliter suggest insulin resistance even if glucose remains normal. Testing DHEA-S reveals adrenal function and can identify adrenal insufficiency or adrenal overactivity. Additionally, DHEA-sulfate, or DHEA-S, is an androgen produced by the adrenal glands. The free testosterone fraction, not bound to binding proteins, is more physiologically active than total testosterone. Polycystic ovary syndrome is characterized by elevated androgens. Although research began decades ago, our understanding of male hormone regulation is continually evolving with new discoveries. Both of them bind avidly to AR and have proved to be safe and well tolerated without serious side effects and reversibly inhibit the hypothalamic–pituitary–testicular axis 201,202. 7α-methyl-19- nortestosterone (MENT, an androgenic–anabolic steroid) has been proven to be more effective in inhibiting pituitary gonadotropin than testosterone and the potential of its subcutaneous implants is being investigated 198,199. Therefore, there is a need for the development of new male hormonal contraceptives that are convenient, effective, reversible, and affordable. However, oral testosterone is cleared too rapidly, hampering the search for safe and effective oral androgens .